SOLV - Solventum Corp Stock Analysis

Solventum Corp (SOLV) is a publicly traded company listed on the . It operates in the industry, part of the broader sector. The company has a market capitalization of 13.57B, generates annual revenue of 8.28B, and reports net income of 1.43B. As of the latest data, the stock is trading at 78.37 USD.

From a valuation and risk perspective, the stock presents the following profile: The stock may be undervalued based on its earnings, though it could also reflect market concerns. The PEG ratio is within a normal range, suggesting the stock is fairly priced for its expected growth. The company uses a significant amount of debt to finance its operations, which can boost returns but adds financial risk. This stock does not currently pay a dividend. This stock tends to be less volatile than the overall market, often preferred by conservative investors.

Analyst recommendation stands at Hold (3.73), indicating current market sentiment. Institutional ownership is reported at 76.57%, reflecting confidence from large investors. Over the last 12 months, the stock has shown a performance of 6.37%, trading within a 52-week range of 62.38 - 88.20.

SOLV - Solventum Corp

78.37
Analyst Consensus
Hold 3.73
SOLV – Analyst Rating Summary
Analyst Pie Chart
  • Strong Buy: 6
  • Buy: 6
  • Hold: 8
  • Sell: 2
  • Strong Sell: 0
  • Total Analysts:  22

Last update: 2026-07-16 04:59:49
Index: S&P 500 P/E: 9.60 EPS (ttm): 8.16 Insider Own: 15.07% Shs Outstand: 173.53M Perf Week: 4.24%
Market Cap: 13.57B Forward P/E: 11.03 EPS next Y: 7.10 Insider Trans: 0.01% Shs Float: 147.07M Perf Month: -0.63%
Income(ttm): 1.43B PEG: 1.29 EPS next Q: 1.90 Inst Own: 76.57% Short Float: 3.42% Perf Quarter: 13.55%
Revenue(ttm): 8.28B P/S: 1.64 EPS this Y: 7.19% Inst Trans: 1.61% Short Ratio: 3.01 Perf Half Y: -8.54%
Book/sh: 28.63 P/B: 2.74 EPS next Y: 8.47% ROA: 10.01% Short Interest: 5.02M Perf Year: 6.37%
Cash/sh: 3.24 P/C: 24.19 EPS next 5Y: 8.52% ROE: 34.80% 52W Range: 62.38 - 88.20 Perf YTD: -1.10%
Dividend Est.: - P/FCF: - EPS past 3/5Y: 4.51% 1.23% ROIC: 14.69% 52W High: 88.20 -11.15% Beta: 0.72
Dividend TTM: - Quick Ratio: 0.75 Sales past 3/5Y: 0.79% 0.47% Gross Margin: 56.60% 52W Low: 62.38 25.63% Perf 5Y: -
Dividend Ex-Date: - Current Ratio: 1.07 EPS Y/Y TTM: 277.03% Oper. Margin: 11.90% RSI (14): 55.04 Volatility: 2.59% 2.84%
Employees: 20000 Debt/Eq: 1.06 Sales Y/Y TTM: -0.28% Profit Margin: 17.29% Recom: 2.39 Target Price: 84.42
Option/Short: Yes / Yes LT Debt/Eq: 0.96 EPS Q/Q: -90.54% Payout: 0.00% Rel Volume: 0.51 Prev Close: 76.28
Sales Surprise: 2.01% EPS Surprise: 9.42% Sales Q/Q: -3.04% Earnings: May 05 AMC Avg Volume: 1.67M Price: 78.37
SMA20: 2.23% SMA50: 2.77% SMA200: 4.90% Undervalued: 7.72%
Volume: 846,200 Change: 2.74%
Graham's revised valuation formula
Discounted cash flow (DCF) model
Margin of safety

About Solventum Corp

Solventum Corp. operates as a health care company. It gives better, smarter, safer healthcare to improve lives. The company was founded on January 24, 2023 and is headquartered in Maplewood, MN.

Attention! Trading on the stock market involves financial risks and is not suitable for everyone. The www.stocks-expert.com does not provide financial market trading services; it is for informational purposes only and is not responsible for the consequences of your trading decisions or the operation of the software. Before starting to trade in any markets, make sure you understand the risks associated with trading and that you have a sufficient level of training.

Copyright © 2024 - 2026 www.stocks-expert.com All Rights Reserved.